Transcription of 審議結果報告書 - pmda.go.jp
{{id}} {{{paragraph}}}
Example: confidence
審議結果報告書 - pmda.go.jp
29 10 .. 25 mg 125 mg .. 28 10 31 .. 29 27 .. 29 7 14 .. 25 mg 125 mg .. 28 10 31 . 1 25 mg 125 mg . 1 .. C24H29N7O2.. 6- -8- -5- -2-{[5-( -1- ) -2- ] . } [2,3-d] -7(8H)- . 6-Acetyl-8-cyclopentyl-5-methyl-2-{ [5-(piperazin-1-yl)pyridin-2-yl] amino} pyrido [2,3-d]. pyrimidin-7(8H)-one .. _ _ .. 1 1 125 mg 3 . 1 1 .. 2. _ _ .. 1 . 29 6 16 .. 25 mg 125 mg .. 28 10 31 . 1 25 mg 125 mg .. 1 . 1 125 mg 3 1 . 1 .. 1.. 6. 2.. 7. 3.. 9. 4.. 15. 5.. 24. 6. 31. 7.. 44. 8.. 81. 9. 1 .. 81.. AGP 1-acid glycoprotein 1- . ALP alkaline phosphatase . ALT alanine aminotransferase . AST aspartate aminotransferase . BA bioavailability . BCRP breast cancer resistance protein . _ _.
イブランスカプセル_ファイザー株式会社_審査報告書 2 BSA bovine serum albumin ウシ血清アルブミン BSEP bile salt export pump 胆汁酸排泄ポンプ
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: